top of page

CBA provides solutions to our clients' needs across the continuum from R&D to market

image.png
image.png
image.png
R&D Strategy
Workflow and Supply Chain Mapping
Commercial Assessment
Corporate and Business Strategy
  • Early-stage valuation and risk assessment

  • Product profile development and testing

  • Pre-launch strategies

  • Probability of technical and regulatory success

  • Go / no-go assessment

  • Product and portfolio assessment

  • Clinical, patient, product, and information flows

  • Monetary flows

  • Stakeholder maps and decision-making

  • Unmet needs analysis

  • Opportunity identification and prioritization

  • Manufacturing, supply-chain, and distribution requirements

  • Customer insights

  • Market opportunity assessment and valuation

  • Stakeholder requirements and values

    • Physicians and patients

    • Payers

    • Regulators

  • Value proposition development

  • Launch strategy

  • Partnering and BD&L support

  • Partnership and M&A landscaping, valuation, and target screening

  • Board of Directors presentation development

  • Strategy development team facilitation

  • Strategic roadmap development

  • Internal and external assessment and gap analysis

  • Market entry and expansion strategies

Result

© 2025 by Cambridge Biostrategy Associates LLC. Proudly created with Wix.com

  • LinkedIn Social Icon
bottom of page